Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Prempro Low Dose is a prescription hormone replacement therapy (HRT) used to relieve certain symptoms of menopause and help prevent bone loss in postmenopausal women.
It contains two active ingredients: conjugated estrogens and medroxyprogesterone acetate.
Conjugated estrogens replace some of the estrogen that the body produces in lower amounts after menopause. Medroxyprogesterone acetate is a progestin, a synthetic form of the hormone progesterone, that helps protect the lining of the uterus from excessive growth caused by estrogen.
Prempro belongs to a class of medications called combined estrogen-progestin therapies. It is generally prescribed to postmenopausal women who still have a uterus.
The medication may help relieve hot flashes, night sweats, vaginal dryness, and other symptoms related to declining estrogen levels. It may also help prevent osteoporosis in selected postmenopausal women.
Prempro Low Dose helps manage moderate to severe menopausal symptoms and may help prevent postmenopausal osteoporosis. Treatment should be individualized and regularly reviewed by a healthcare provider.Â
Prempro Low Dose is commonly prescribed to relieve moderate to severe symptoms associated with menopause.
Menopause is a natural stage of life that occurs when menstrual periods permanently stop because the ovaries produce significantly less estrogen and progesterone.
These hormonal changes may cause physical and emotional symptoms that interfere with sleep, comfort, and everyday activities.
Common symptoms include hot flashes, night sweats, vaginal dryness, and sleep disturbances.
Some women may also experience mood changes, fatigue, and reduced quality of life during the menopausal transition.
Prempro helps replace declining estrogen levels, which may reduce the frequency and severity of certain menopause-related symptoms.
The addition of medroxyprogesterone acetate helps protect the uterine lining from excessive growth that may occur when estrogen is taken without a progestin.
However, Prempro is not suitable for every woman. Your healthcare provider will consider your symptoms, age, medical history, and risk factors before recommending treatment.
Prempro Low Dose helps relieve moderate to severe menopausal symptoms by replacing estrogen and providing progestin protection for the uterine lining.
Hot flashes are among the most common symptoms experienced during menopause.
A hot flash is a sudden sensation of intense warmth, often affecting the face, neck, and chest.
It may be accompanied by sweating, skin redness, a rapid heartbeat, or feelings of discomfort.
Some women experience occasional hot flashes, while others have frequent episodes that interfere with work, sleep, and daily activities.
Night sweats are hot flashes that occur during sleep, often causing excessive sweating and repeated awakenings.
These symptoms are associated with changes in estrogen levels that affect the body’s temperature regulation.
Prempro Low Dose helps stabilize estrogen-related signalling involved in body temperature control.
With treatment, many women experience fewer hot flashes and less severe night sweats.
Improvement may also lead to better sleep and increased comfort throughout the day.
However, the response varies, and your healthcare provider may need to adjust treatment depending on symptom control and tolerability.
Prempro Low Dose may help reduce the frequency and severity of hot flashes and night sweats, improving comfort and sleep during menopause.
Prempro Low Dose may also help relieve moderate to severe vulvar and vaginal symptoms caused by menopause.
As estrogen levels decline, vaginal tissues may become thinner, drier, and less elastic.
These changes can cause vaginal dryness, irritation, burning, and discomfort during sexual activity.
Some women may also experience reduced natural lubrication and increased sensitivity of vaginal tissues.
These symptoms are part of a condition commonly known as genitourinary syndrome of menopause (GSM).
Prempro provides estrogen that can help improve the condition of estrogen-sensitive vaginal tissues.
This may reduce dryness and discomfort and improve vaginal moisture and elasticity.
However, when vaginal dryness or discomfort is the only menopausal symptom requiring treatment, localized vaginal estrogen or other vaginal treatments are generally preferred because they can provide relief with less systemic hormone exposure.
Your healthcare provider will determine whether systemic hormone therapy is appropriate based on your symptoms and medical history.
Prempro Low Dose may help relieve vaginal dryness and discomfort associated with menopause. If vaginal symptoms are your only concern, your healthcare provider may recommend a localized treatment instead.Â
Prempro Low Dose may be prescribed to help prevent osteoporosis in certain postmenopausal women.
Osteoporosis is a condition in which bones become less dense and more fragile, increasing the risk of fractures.
Estrogen plays an important role in maintaining bone strength by helping regulate the balance between bone breakdown and bone formation.
After menopause, declining estrogen levels can accelerate bone loss.
Over time, this may increase the risk of fractures, particularly in the hips, wrists, and spine.
Prempro helps replace estrogen, which can slow bone loss and help maintain bone mineral density.
However, hormone therapy is not usually the first treatment choice when osteoporosis prevention is the only goal.
Prempro should generally be considered for osteoporosis prevention only in women at significant risk of bone loss or fractures, after carefully evaluating non-estrogen treatment options.
Your healthcare provider may also recommend adequate calcium and vitamin D intake, regular weight-bearing exercise, and other measures to support bone health.
Prempro Low Dose may help prevent postmenopausal bone loss, but its benefits must be weighed against the potential risks of hormone therapy. Non-estrogen treatments should also be considered.Â
Prempro Low Dose contains two hormones that work together to manage the effects of declining estrogen levels after menopause.
Conjugated Estrogens: Replace Declining Estrogen Levels
Estrogen is a hormone that helps regulate reproductive tissues, body temperature, and bone health.
During menopause, estrogen production decreases significantly.
This decline contributes to hot flashes, night sweats, vaginal dryness, and accelerated bone loss.
The conjugated estrogens in Prempro help replace some of the missing estrogen and reduce symptoms associated with menopause.
They also help maintain bone density by slowing the rate at which bone is broken down.
Medroxyprogesterone Acetate: Protects the Uterine Lining
Medroxyprogesterone acetate is a synthetic progestin that helps protect the endometrium, the inner lining of the uterus.
Estrogen stimulates growth of the uterine lining.
When estrogen is used without adequate progestin protection in a woman who still has a uterus, the lining may become excessively thick.
This condition, known as endometrial hyperplasia, can increase the risk of endometrial cancer.
Medroxyprogesterone acetate helps counteract estrogen’s effects on the uterine lining, reducing the risk of excessive growth.
Combined Hormone Therapy
By combining estrogen and progestin, Prempro helps relieve menopausal symptoms while providing protection against estrogen-induced endometrial hyperplasia.
However, adding a progestin does not eliminate all the risks associated with systemic hormone therapy.
Prempro Low Dose works by replacing estrogen to relieve menopausal symptoms and support bone health, while medroxyprogesterone acetate helps protect the uterine lining.
The time needed for Prempro Low Dose to provide noticeable relief varies depending on the symptoms being treated and individual response.
Some women may notice improvements in hot flashes and night sweats within the first few weeks of treatment.
However, more substantial symptom relief may take several weeks to a few months.
Vaginal dryness and discomfort may also improve gradually as estrogen-sensitive tissues respond to treatment.
When Prempro is prescribed to help prevent osteoporosis, the benefits are not usually noticeable through immediate physical changes.
Instead, estrogen helps slow bone loss over time.
Your healthcare provider may recommend periodic assessments to determine whether treatment remains necessary and effective.
Do not increase the dosage if you do not experience immediate improvement.
Prempro Low Dose may begin relieving menopausal symptoms within several weeks, but the full response varies. Bone-protective effects develop over time and may require ongoing monitoring.
Prempro Low Dose is available as oral tablets containing conjugated estrogens and medroxyprogesterone acetate. Low-dose formulations include 0.3 mg/1.5 mg and 0.45 mg/1.5 mg, although availability varies by country.
It is generally taken once daily, with or without food, as prescribed by a healthcare provider.
Common side effects may include breast tenderness, headaches, nausea, bloating, and irregular vaginal bleeding.
More serious risks associated with combined systemic hormone therapy include blood clots, stroke, heart attack, breast cancer, and, in older women, an increased risk of probable dementia.
Prempro should not be used to prevent heart disease or dementia.
It is also not appropriate for women with certain medical conditions, including a history of breast cancer, unexplained vaginal bleeding, active or previous blood clots, certain clotting disorders, or significant liver disease.
Hormone therapy should generally be prescribed at the lowest effective dose for the shortest duration consistent with the patient’s treatment goals and risks, with regular reassessment.
Seek urgent medical attention if you develop chest pain, sudden shortness of breath, one-sided leg swelling, sudden weakness, difficulty speaking, or other symptoms suggesting a blood clot, heart attack, or stroke. Report any unexplained vaginal bleeding to your healthcare provider.
Prempro Low Dose is a prescription hormone replacement therapy (HRT) used to relieve moderate to severe menopausal symptoms, including hot flashes, night sweats, and vaginal dryness. It may also be prescribed to help prevent osteoporosis in selected postmenopausal women.
It contains two active ingredients: conjugated estrogens and medroxyprogesterone acetate. These hormones work together to replace declining estrogen levels while helping protect the lining of the uterus from excessive growth.
Prempro Low Dose is available as an oral tablet that is generally taken once daily, with or without food.
Your healthcare provider will determine the appropriate dosage based on your symptoms, medical history, treatment goals, and potential risks.
Take Prempro Low Dose exactly as prescribed. Use the lowest effective dose for the shortest duration consistent with your treatment goals and individual risks.
Prempro Low Dose should be taken by mouth according to your healthcare provider’s instructions.
Swallow the prescribed tablet with a glass of water. You may take the medication with or without food.
If you experience mild nausea or stomach discomfort, taking Prempro Low Dose with a meal or immediately after eating may help improve tolerance.
The medication is generally taken once daily. Try to take your tablet at approximately the same time each day to maintain a consistent routine and reduce the likelihood of missing doses.
Prempro is designed for continuous hormone therapy, so the tablets are taken every day rather than only when menopausal symptoms occur.
Do not increase your dosage or take additional tablets if your symptoms continue.
Your healthcare provider may adjust your treatment if symptoms remain uncontrolled or you experience unwanted side effects.
Take one prescribed tablet daily, preferably at the same time each day. Prempro Low Dose may be taken with or without food, although taking it with a meal may help reduce stomach upset.
The usual recommended dosage of Prempro Low Dose is one tablet taken by mouth once daily.
The medication is available in different hormone strengths, and your healthcare provider will select the formulation that is most appropriate for your symptoms and medical history.
Prempro tablets are generally taken continuously throughout the month.
Each 28-day treatment period consists of taking one tablet daily for 28 consecutive days, followed by the next 28-day supply without a scheduled break.
This continuous schedule helps maintain hormone levels and provide ongoing relief from menopausal symptoms.
However, the appropriate dosage and duration vary between patients.
Your healthcare provider will consider factors such as your age, how long you have been postmenopausal, the severity of your symptoms, and your risk of blood clots, cardiovascular disease, and certain cancers.
Hormone therapy should generally be started at the lowest effective dose and reassessed periodically.
The usual dosage is one tablet once daily, taken continuously without a scheduled break between 28-day supplies. Follow the exact strength and dosing instructions provided by your healthcare provider.
Prempro Low Dose is generally prescribed at the lowest dosage that adequately controls menopausal symptoms.
Although hormone therapy can relieve hot flashes, night sweats, and other menopause-related discomfort, systemic estrogen-progestin therapy carries certain health risks.
These may include blood clots, stroke, heart attack, and breast cancer.
The risks depend on several factors, including age, medical history, the type of hormone therapy, and treatment duration.
Using the lowest effective dose helps avoid unnecessary hormone exposure while still providing symptom relief.
Your healthcare provider will regularly review whether the medication continues to provide sufficient benefits.
If your symptoms improve, your healthcare provider may consider adjusting the dose or discussing whether continued treatment is necessary.
Do not reduce or discontinue your medication independently.
Use Prempro Low Dose at the lowest effective dose for the shortest duration appropriate to your individual treatment goals and risks. Regular medical assessments are important throughout treatment.
If you forget to take a dose of Prempro Low Dose, take it as soon as you remember.
However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
Do not take two tablets at the same time or use extra medication to make up for a missed dose.
Taking more than the prescribed amount may increase the likelihood of side effects, including nausea, breast tenderness, and vaginal bleeding.
If you frequently miss doses, consider setting a daily reminder or incorporating your medication into a regular morning or evening routine.
If you miss several consecutive doses, contact your healthcare provider or pharmacist for advice about resuming treatment.
Never double your Prempro Low Dose dosage to compensate for a missed tablet. Continue your normal schedule unless your healthcare provider advises otherwise.Â
The duration of treatment depends on the severity of your menopausal symptoms, individual health risks, and response to hormone therapy.
Some women may need treatment for a relatively short period, while others may benefit from continuing therapy for longer.
Your healthcare provider will regularly assess whether Prempro Low Dose is still necessary and whether the benefits continue to outweigh the risks.
The manufacturer recommends discussing your treatment needs with your healthcare provider approximately every three to six months.
During these appointments, your healthcare provider may review your menopausal symptoms, current dosage, medical history, and any new health concerns.
Do not stop taking the medication or change your dosage without discussing your treatment plan.
Continue Prempro Low Dose only for as long as medically appropriate. Regular treatment reviews help ensure that you receive the lowest effective dose while minimizing unnecessary risks.Â
Prempro Low Dose should only be used under the supervision of a healthcare provider because combined hormone therapy carries certain health risks.
Possible side effects include nausea, breast tenderness, headaches, bloating, and irregular vaginal bleeding.
More serious risks include blood clots, stroke, heart attack, and an increased risk of breast cancer with combined hormone therapy.
Tell your healthcare provider if you have a history of blood clots, cardiovascular disease, breast cancer, liver disease, or unexplained vaginal bleeding.
Contact your healthcare provider if you experience persistent side effects or unexpected vaginal bleeding.
Seek emergency medical attention if you develop sudden chest pain, shortness of breath, one-sided leg swelling, severe headaches with neurological symptoms, or difficulty speaking.
Take Prempro Low Dose once daily as prescribed, never double missed doses, and attend regular follow-up appointments. Use the lowest effective dose for the shortest duration appropriate to your treatment goals and medical risks.
Prempro Low Dose (Medroxyprogesterone/Estrogen) is available in the following forms and strength:
Prempro Low Dose is a prescription hormone replacement therapy (HRT) used to relieve moderate to severe menopausal symptoms, including hot flashes, night sweats, and vaginal dryness. It may also be prescribed to help prevent osteoporosis in selected postmenopausal women.
It contains two active ingredients: conjugated estrogens and medroxyprogesterone acetate. These hormones work together to replace declining estrogen levels while helping protect the uterine lining from excessive growth.
Although Prempro Low Dose can provide relief from menopausal symptoms, it carries certain health risks, including an increased risk of blood clots, stroke, heart attack, and breast cancer.
The risk of complications depends on several factors, including age, medical history, existing health conditions, and duration of treatment.
Prempro Low Dose should only be used under medical supervision. Hormone therapy should be prescribed at the lowest effective dose for the shortest duration consistent with individual treatment goals and risks.Â
Prempro Low Dose may increase the risk of certain cardiovascular complications, including heart attack, stroke, and blood clots.
Estrogen-progestin therapy can affect blood clotting and may increase the likelihood of a clot forming inside a blood vessel.
A blood clot that develops in a deep vein, usually in the leg, is called deep vein thrombosis (DVT).
If part of the clot travels to the lungs, it can cause a potentially life-threatening condition called pulmonary embolism (PE).
Clinical studies involving combined estrogen-progestin therapy have also identified increased risks of heart attack and stroke in certain postmenopausal women.
The risk may be greater in women who smoke, have high blood pressure, or have other cardiovascular risk factors.
Patients with a history of heart attack, stroke, DVT, or pulmonary embolism should not use Prempro.
Prempro should not be prescribed to prevent heart disease or other cardiovascular conditions.
Symptoms of serious cardiovascular complications may include sudden chest pain, difficulty breathing, swelling or pain in one leg, sudden weakness, or difficulty speaking.
Seek emergency medical attention if you experience chest pain, sudden shortness of breath, one-sided leg swelling, or symptoms of a stroke. Tell your healthcare provider about any history of cardiovascular disease or blood clots before starting Prempro.Â
Prempro Low Dose may increase the risk of breast cancer, particularly when combined estrogen-progestin therapy is used for an extended period.
Breast cancer develops when abnormal cells in breast tissue grow uncontrollably.
Studies of combined hormone therapy have shown an increased risk of invasive breast cancer compared with placebo.
The risk may increase with longer treatment duration, although individual risk depends on several factors.
Women with a personal history of breast cancer should not use Prempro.
Patients with a family history of breast cancer should discuss their individual risk factors with their healthcare provider before starting treatment.
During therapy, patients should remain aware of changes in their breasts.
Possible warning signs include a new breast lump, unusual breast swelling, nipple discharge, or changes in breast shape or skin appearance.
Regular breast examinations and recommended mammograms remain important during treatment.
Your healthcare provider will periodically assess whether the benefits of continuing Prempro outweigh the potential risks.
Prempro Low Dose may increase breast cancer risk, particularly with prolonged combined hormone therapy. Report any unusual breast changes promptly and attend recommended breast screening appointments.
Estrogen therapy can increase the risk of endometrial cancer when used without a progestin in women who still have a uterus.
The endometrium is the inner lining of the uterus.
Estrogen stimulates the growth of this lining. When estrogen is taken without sufficient progestin protection, the endometrium may become excessively thick.
This condition is known as endometrial hyperplasia, which can increase the risk of endometrial cancer.
Prempro contains medroxyprogesterone acetate, a progestin that helps counteract the effects of estrogen on the uterine lining.
Adding a progestin significantly reduces the risk of estrogen-induced endometrial hyperplasia compared with estrogen-only therapy.
However, this protection does not eliminate every possible cause of endometrial cancer.
Women taking Prempro should report unexplained, persistent, or recurring vaginal bleeding to their healthcare provider.
Unexpected bleeding may require examination to rule out endometrial abnormalities or other medical conditions.
Prempro contains a progestin to help protect the uterine lining. However, unexplained or persistent vaginal bleeding must be medically evaluated to rule out potentially serious conditions.Â
Combined estrogen-progestin therapy may increase the risk of probable dementia in women aged 65 years and older.
Dementia is a condition characterized by a decline in memory, thinking, reasoning, and other cognitive abilities that interfere with everyday activities.
The Women’s Health Initiative Memory Study found an increased risk of probable dementia in postmenopausal women aged 65 and older who received a particular regimen of conjugated estrogens and medroxyprogesterone acetate.
It is not known whether the same degree of risk applies to women who begin hormone therapy at a younger age or to every hormone formulation and dosage.
However, Prempro should not be prescribed for the prevention of dementia or memory decline.
Patients who are concerned about memory problems or cognitive changes should discuss these symptoms with their healthcare provider.
Your healthcare provider will consider your age, medical history, and treatment goals when deciding whether systemic hormone therapy is appropriate.
Prempro Low Dose should not be used to prevent dementia. Combined hormone therapy has been associated with an increased risk of probable dementia in women aged 65 years and older.Â
Prempro Low Dose may cause side effects as the body adjusts to hormone replacement therapy.
Common side effects include headaches, nausea, breast tenderness, bloating, fluid retention, and irregular vaginal bleeding.
Some women may also experience mood changes, abdominal discomfort, or changes in vaginal discharge.
Headaches and Nausea
Headaches and mild nausea may occur during treatment. Taking Prempro with food may help reduce stomach discomfort.
Bloating and Fluid Retention
Hormone therapy may cause the body to retain additional fluid, leading to bloating, swelling, or a feeling of fullness.
Breast Tenderness
Some women may experience breast discomfort or increased sensitivity because of changes in hormone levels.
Vaginal Bleeding
Irregular spotting or breakthrough bleeding may occur, particularly during the early stages of treatment.
However, persistent, heavy, or unexplained bleeding should not be ignored.
Mood Changes
Some patients may notice changes in mood or emotional well-being during hormone therapy.
If these changes become severe or interfere with daily activities, contact your healthcare provider.
Report persistent or troublesome side effects to your healthcare provider. Seek prompt medical evaluation for unexplained vaginal bleeding, severe headaches, or significant swelling.
Prempro Low Dose is intended for postmenopausal women and should not be used during pregnancy.
The medication contains estrogen and progestin hormones and is not intended to support pregnancy or treat pregnancy-related conditions.
If you become pregnant or suspect that you may be pregnant while taking Prempro, stop taking the medication and contact your healthcare provider for advice.
Prempro is also not recommended during breastfeeding.
Estrogen-containing medications may reduce the quantity and quality of breast milk, particularly when started before milk production is well established.
Small amounts of estrogen and progestin may also pass into breast milk.
Your healthcare provider can recommend an appropriate treatment if you are experiencing hormonal symptoms while breastfeeding.
Prempro Low Dose should not be used during pregnancy or breastfeeding. It is intended for the treatment of certain postmenopausal conditions.Â
Patients with liver or kidney disease should discuss their medical history with their healthcare provider before using Prempro.
The liver plays an important role in processing estrogen and progestin hormones.
Patients with liver impairment may have difficulty metabolizing these hormones, potentially increasing the risk of adverse effects.
Prempro is contraindicated in patients with hepatic impairment or liver disease.
Kidney disease also requires medical assessment, particularly if the patient experiences fluid retention or has other cardiovascular conditions.
Hormone therapy may contribute to fluid retention, which can worsen certain medical conditions.
Your healthcare provider will determine whether Prempro is appropriate based on your kidney function, medical history, and other treatments.
Do not use Prempro if you have liver disease or hepatic impairment. Tell your healthcare provider about kidney problems or fluid retention before starting hormone therapy.Â
Prempro may increase the risk of gallbladder disease in certain patients.
The gallbladder stores bile, a digestive fluid produced by the liver that helps break down fats.
Estrogen therapy can affect the composition of bile and may increase the likelihood of gallstone formation.
Gallstones are hardened deposits that develop inside the gallbladder and may interfere with normal bile flow.
Symptoms may include pain in the upper right abdomen, nausea, vomiting, and discomfort after eating fatty meals.
Some patients may develop inflammation of the gallbladder, which can require medical treatment.
Women with a history of gallstones or gallbladder disease should inform their healthcare provider before starting Prempro.
Tell your healthcare provider if you have gallstones or a history of gallbladder disease. Seek medical attention if you develop severe upper abdominal pain, fever, or persistent vomiting.
Patients with high blood pressure or diabetes should use Prempro only after a healthcare provider has assessed their individual risk factors.
High blood pressure is an important risk factor for heart attack and stroke.
Because systemic estrogen-progestin therapy may increase cardiovascular risks, patients with hypertension may require careful monitoring.
Diabetes can also increase the risk of cardiovascular disease, particularly when blood glucose levels remain poorly controlled.
Hormone therapy may affect glucose tolerance in some patients, although these effects vary.
Your healthcare provider may recommend monitoring blood pressure, blood glucose, and other cardiovascular risk factors throughout treatment.
Do not change your blood pressure or diabetes medications without medical advice.
Tell your healthcare provider if you have high blood pressure or diabetes. Regular monitoring may be necessary to ensure that hormone therapy remains appropriate for your health needs.
Patients with asthma should inform their healthcare provider before starting Prempro.
Although asthma is not a general contraindication to hormone replacement therapy, estrogen-containing medications can contribute to fluid retention in some patients.
Patients with medical conditions that may worsen because of fluid retention may require additional monitoring.
These conditions can include asthma, epilepsy, migraines, heart failure, and certain kidney disorders.
Your healthcare provider will consider your symptoms, medical history, and existing medications before recommending treatment.
If you experience worsening breathing difficulties, unusual swelling, or other significant changes in your health, contact your healthcare provider.
Tell your healthcare provider about asthma, migraines, epilepsy, fluid retention, or other chronic medical conditions before starting Prempro.
Prempro Low Dose may interact with medications that affect how estrogen and medroxyprogesterone acetate are processed in the body.
Certain medications can increase or decrease hormone concentrations, potentially affecting treatment effectiveness or increasing the likelihood of side effects.
For example, some medications used to treat seizures, such as carbamazepine and phenytoin, may increase the breakdown of estrogen hormones.
Rifampin, an antibiotic used to treat certain bacterial infections, can also affect hormone metabolism.
Some antifungal medications and other drugs that influence liver enzymes may alter hormone levels.
Herbal products, including St. John’s wort, may also affect the metabolism of certain medications.
Patients taking thyroid hormone replacement therapy may require additional monitoring because estrogen can affect the amount of thyroid hormone-binding proteins in the blood.
Before starting Prempro, tell your healthcare provider about all prescription medications, over-the-counter products, vitamins, and herbal supplements you take.
Do not start, stop, or change medications or herbal supplements without consulting your healthcare provider or pharmacist. Certain products may affect the safety or effectiveness of Prempro.
Unexplained vaginal bleeding requires medical attention, particularly in postmenopausal women.
Although some spotting may occur during the early stages of hormone therapy, persistent, recurring, or heavy bleeding may indicate an underlying medical condition.
Possible causes include changes in the uterine lining, polyps, or other gynecological conditions.
In some cases, abnormal bleeding may be associated with endometrial hyperplasia or endometrial cancer.
Your healthcare provider may recommend a pelvic examination, ultrasound, or other tests to determine the cause.
Prempro should not be started in patients with undiagnosed abnormal genital bleeding.
Patients should also report unusual breast changes, severe headaches, significant swelling, or other unexplained symptoms during treatment.
Contact your healthcare provider promptly if you experience unexplained vaginal bleeding, persistent spotting, or other unusual symptoms while taking Prempro. Do not ignore bleeding that develops after menopause.
Prempro Low Dose is a combined estrogen-progestin medication used to relieve menopausal symptoms and help prevent osteoporosis in selected postmenopausal women.
Although it can be effective, treatment may increase the risk of blood clots, stroke, heart attack, breast cancer, and other serious complications.
The risks depend on the patient’s age, medical history, hormone dosage, and duration of treatment.
Women with certain conditions, including a history of breast cancer, blood clots, stroke, heart attack, liver disease, or unexplained vaginal bleeding, should not use Prempro.
Regular medical assessments are important to determine whether the benefits of treatment continue to outweigh the potential risks.
Seek emergency medical attention if you experience chest pain, sudden difficulty breathing, severe headache with neurological symptoms, one-sided leg swelling, or signs of a stroke. Use Prempro at the lowest effective dose for the shortest duration appropriate to your treatment goals and medical risks.
Yes. Prempro Low Dose may increase the risk of breast cancer, particularly when combined estrogen-progestin hormone therapy is used for an extended period. Prempro contains conjugated estrogens and medroxyprogesterone acetate, which help relieve menopausal symptoms by replacing declining hormone levels. However, these hormones can also influence the growth of certain breast cells. Clinical studies involving combined estrogen-progestin therapy have shown an increased risk of invasive breast cancer compared with placebo. The risk may become greater with longer treatment duration, although individual risk depends on factors such as age, family history, and previous hormone exposure. Women with a history of breast cancer or known or suspected breast cancer should not use Prempro. Those with a family history of breast cancer should discuss their individual risk factors with their healthcare provider before starting treatment. Regular breast examinations and mammograms are important during hormone therapy. Patients should also report any unusual breast changes, including new lumps, nipple discharge, swelling, or changes in breast appearance. Your healthcare provider will periodically assess whether the benefits of continuing Prempro outweigh its potential risks. Prempro Low Dose may increase breast cancer risk, particularly with prolonged use. Regular breast screening and medical follow-up are important, and patients should report unusual breast changes promptly.
Yes. Prempro Low Dose may increase the risk of certain cardiovascular complications, including heart attack, stroke, deep vein thrombosis (DVT), and pulmonary embolism. Combined estrogen-progestin therapy can affect blood clotting and may increase the likelihood of blood clots developing inside blood vessels. A blood clot that forms in a deep vein, usually in the leg, is called deep vein thrombosis. If part of the clot travels to the lungs, it may cause a potentially life-threatening pulmonary embolism. Hormone therapy has also been associated with an increased risk of heart attack and stroke in certain postmenopausal women. The risk may be higher in women who smoke, have high blood pressure, are older, or have other cardiovascular risk factors, such as diabetes, obesity, or a history of blood clots. Women with a history of heart attack, stroke, DVT, or pulmonary embolism should not use Prempro. Before prescribing Prempro, your healthcare provider will assess your cardiovascular health and determine whether the potential benefits of treatment outweigh the risks. Prempro should not be used to prevent heart disease or stroke. Prempro Low Dose may increase the risk of blood clots and cardiovascular complications. Seek emergency medical attention if you develop sudden chest pain, difficulty breathing, one-sided leg swelling, or symptoms of a stroke.
No. Prempro Low Dose is intended for postmenopausal women and should not be used during pregnancy or breastfeeding. Prempro contains conjugated estrogens and medroxyprogesterone acetate, which are used to manage symptoms associated with declining hormone levels after menopause. These hormones are not intended to support pregnancy or treat pregnancy-related conditions. Prempro is contraindicated during pregnancy. If you become pregnant or suspect that you may be pregnant while taking Prempro, stop using the medication and contact your healthcare provider for further guidance. Prempro is also not recommended during breastfeeding because estrogen and progestin hormones may pass into breast milk. Estrogen-containing medications can also reduce milk production, particularly when taken before breastfeeding is well established. If you are breastfeeding and experiencing symptoms that require medical treatment, your healthcare provider can recommend a more appropriate option. Prempro Low Dose should not be used during pregnancy or breastfeeding. Contact your healthcare provider if you become pregnant while taking the medication or need treatment while nursing.
No. Prempro Low Dose is not suitable or necessary for every woman experiencing menopause. Menopause is a natural stage of life, and the severity of symptoms varies significantly between individuals. Some women experience mild hot flashes, occasional night sweats, or vaginal dryness that can be managed without systemic hormone therapy. Others develop moderate to severe symptoms that interfere with sleep, daily activities, and overall quality of life. Prempro Low Dose may be considered for women with a uterus who experience significant menopausal symptoms and whose individual benefits of treatment outweigh the risks. However, certain medical conditions can make combined hormone therapy unsuitable. Women with a history of breast cancer, unexplained vaginal bleeding, blood clots, stroke, heart attack, or significant liver disease should not use Prempro. Patients with other conditions, including high blood pressure, diabetes, migraines, or gallbladder disease, may require additional assessment before starting treatment. Women who have undergone a hysterectomy may not need the progestin component of Prempro, as progestin is primarily included to protect the uterine lining. For women whose only menopausal symptoms are vaginal dryness or discomfort, localized vaginal treatments may be more appropriate because they generally involve less systemic hormone exposure. Nonhormonal treatments are also available for certain menopausal symptoms. Your healthcare provider will consider your age, time since menopause, medical history, symptom severity, and personal treatment preferences before recommending an appropriate option. If Prempro is prescribed, treatment should be regularly reviewed to determine whether it remains necessary. Prempro Low Dose is not appropriate for every woman experiencing menopause. Hormone therapy should be individualized based on symptom severity, medical history, and the balance of potential benefits and risks.
| Generic name: | Medroxyprogesterone/Estrogen |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 1.5/0.3mg |
| Quantities Available: | 84days |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Prempro Low Dose (medroxyprogesterone/estrogen) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Prempro Low Dose is commonly prescribed in a daily dosage of 1.5 mg medroxyprogesterone acetate and 0.3 mg conjugated estrogens, taken once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).
No, we do not sell medroxyprogesterone/estrogen directly on our website. However, you can still enjoy low prices on Prempro Low Dose, which contains medroxyprogesterone/estrogen as active ingredients. To purchase Prempro Low Dose, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Prempro Low Dose (medroxyprogesterone/estrogen) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Prempro Low Dose (Medroxyprogesterone/Estrogen). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Prempro Low Dose (Medroxyprogesterone/Estrogen).
REVIEWS